Walleye Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2K Buy
+47
New +$12.4K ﹤0.01% 4460
2025
Q4
Sell
-367
Closed -$97.5K 4876
2025
Q3
$105K Sell
367
-585
-61% -$157K ﹤0.01% 3688
2025
Q2
$250K Sell
952
-31,038
-97% -$7.56M ﹤0.01% 3195
2025
Q1
$7.45M Sell
31,990
-480
-1% -$116K 0.03% 569
2024
Q4
$7.45M Sell
32,470
-26,131
-45% -$5.99M 0.02% 822
2024
Q3
$13.1M Buy
58,601
+6,777
+13% +$1.49M 0.03% 551
2024
Q2
$10.5M Buy
51,824
+7,078
+16% +$1.44M 0.02% 721
2024
Q1
$9.78M Buy
+44,746
New +$9.86M 0.02% 842
2023
Q4
Sell
-3,880
Closed -$815K 5254
2023
Q3
$780K Buy
3,880
+667
+21% +$141K ﹤0.01% 2458
2023
Q2
$666K Buy
+3,213
New +$623K ﹤0.01% 2213
2022
Q2
Sell
-3,394
Closed -$769K 2554
2022
Q1
$769K Buy
+3,394
New +$798K 0.02% 763
2019
Q4
Sell
-47
Closed -$7K 2051
2019
Q3
$7K Buy
+47
New +$6.86K ﹤0.01% 1790

Other funds holding LH

Walleye Capital's LH Position: Q2 2026 in Review

Walleye Capital opened a new position in Labcorp (LH) in Q2 2026: 47 shares worth $13.2K. The stake represents ﹤0.01% of the portfolio and ranks #4460 among its holdings. This is a return to the name: Walleye Capital previously reported a position in LH as recently as Q3 2025.

Walleye Capital first reported a position in LH in Q3 2019 and has held it in 12 quarters since. The position peaked at $13.1M in Q3 2024. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Walleye Capital held 47 shares of Labcorp worth $13.2K as of Q2 2026.
  • Labcorp was a new Walleye Capital position in Q2 2026.
  • Labcorp made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4460 holding.
  • Walleye Capital first reported a position in Labcorp in Q3 2019 and has held it in 12 quarters since.
  • Walleye Capital's Labcorp position peaked at $13.1M in Q3 2024.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.